Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Concerns about fertility affect treatment decisions in one-third of young breast cancer patients


Study highlights need for better patient-physician communication about fertility

A new study shows that concern about infertility resulting from breast cancer therapy influenced treatment decisions in nearly one-third of young patients. The study – the largest to date to examine fertility concerns among young women with breast cancer – found that the majority of the women were very concerned about the ability to have a child as well as the impact that pregnancy might have on disease recurrence, despite the relative lack of data on these risks. The study will be published in the October 15 issue of the Journal of Clinical Oncology.

"These findings indicate that women may overestimate infertility risk, and highlight the need for enhanced communication between physicians and patients," said Ann H. Partridge, MD, MPH, Medical Oncologist at Dana-Farber Cancer Institute, Instructor in Medicine at Harvard Medical School, and lead author of the study. "A key challenge in discussing these issues is the lack of comprehensive data on how cancer therapy affects fertility, particularly when considering newer chemotherapy regimens, and whether getting pregnant after therapy affects the risk of disease recurrence."

Over 11,500 women under the age of 40 are diagnosed with breast cancer each year in the United States. Some breast cancer therapies may cause women to stop menstruating, either temporarily or permanently, and women who continue to have normal menstrual cycles may go through menopause earlier or may be less fertile following chemotherapy than their peers. In addition, while standard hormone-based cancer therapies do not typically cause permanent infertility, they often require years of treatment during which women are advised not to become pregnant.

Researchers surveyed 657 members of the Young Survival Coalition (YSC), a breast cancer patient advocacy group, on their attitudes about fertility. Members were required to be premenopausal and age 40 years or younger at the time of breast cancer diagnosis.

Fifty-seven percent of patients reported being very concerned about becoming infertile, regardless of their age or stage of disease, and 29% said concern about infertility influenced their decisions about treatment. Seventy-two percent discussed fertility issues with their doctors, and 17% discussed these issues with fertility specialists. While 51% of women felt satisfied after discussing the issue with their doctors, 26% felt that their fertility concerns had not been adequately addressed.

The researchers highlighted the need for more data on the impact of treatment on fertility, as well as the development of new approaches to preserving fertility in women treated for breast cancer.

"Young cancer patients have very few options for preserving their fertility, which further complicates treatment decisions," said Dr. Partridge. "Additional research in these areas will help physicians and patients select treatments that are optimized to meet both medical and future fertility goals."

Carrie Housman | EurekAlert!
Further information:

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Discover New Anti-Cancer Protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.

The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...

Im Focus: Researchers at Fraunhofer monitor re-entry of Chinese space station Tiangong-1

In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.

Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...

Im Focus: Alliance „OLED Licht Forum“ – Key partner for OLED lighting solutions

Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.

They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...

Im Focus: Mars' oceans formed early, possibly aided by massive volcanic eruptions

Oceans formed before Tharsis and evolved together, shaping climate history of Mars

A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...

Im Focus: Tiny implants for cells are functional in vivo

For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.

In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Virtual reality conference comes to Reutlingen

19.03.2018 | Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

Latest News

Modular safety concept increases flexibility in plant conversion

22.03.2018 | Trade Fair News

New interactive map shows climate change everywhere in world

22.03.2018 | Earth Sciences

New technologies and computing power to help strengthen population data

22.03.2018 | Earth Sciences

Science & Research
Overview of more VideoLinks >>>